How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Bio-Banks Market
- By Sample Type: Human Biological Samples, Animal Biological Samples, Plant Biological Samples, Microbial Samples, Environmental Samples
- By Storage Type: Cryogenic Storage, Refrigerated Storage, Room Temperature Storage, Liquid Nitrogen Storage
- By End User: Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Hospitals and Clinics, Government and Public Health Organizations, Contract Research Organizations (CROs)
- By Application: Genomic Research, Drug Discovery and Development, Personalized Medicine, Epidemiological Studies, Translational Research
- By Service Type: Sample Collection and Processing, Sample Storage and Preservation, Data Management and Analytics, Sample Distribution and Logistics
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Human Biological Samples leads By Sample Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 300 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.182 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.190 →
Full report · locked preview
Everything inside the Bio-Banks Market report
A complete, evidence-based study - 12 chapters and 126 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Sample Type 5
Storage Type 4
End User 5
Application 5
Service Type 4
Companies profiled
Thermo Fisher Scientific
Sartorius AG
QIAGEN N.V.
Brooks Life Sciences
Cytiva (part of Danaher Corporation)
Corning Incorporated
Greiner Bio-One International GmbH
Nexcelom Bioscience LLC
Hamilton Company
Azenta Life Sciences
Biocair
BioreclamationIVT
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Thermo Fisher Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Sartorius AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →QIAGEN N.V.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Brooks Life Sciences
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Cytiva (part of Danaher Corporation)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Corning Incorporated
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Greiner Bio-One International GmbH
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Nexcelom Bioscience LLC
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Hamilton Company
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Azenta Life Sciences
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Biocair
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →BioreclamationIVT
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →BioStorage Technologies
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Biomatrica
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →VWR International (part of Avantor)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$2,689M by 2033 · 8.1% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Human Biological Samples43.0
- Animal Biological Samples17.7
- Plant Biological Samples9.6
- Microbial Samples12.6
- Environmental Samples17.0
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$475.6M → $922.3M · 8.6%
Europe$331.5M → $677.9M · 9.4%
Asia Pacific$302.7M → $512.3M · 6.8%
Latin America$187.4M → $361.8M · 8.6%
Middle East and Africa$144.1M → $246.7M · 6.9%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →8.062026
8.082027
8.072028
8.082029
8.102030
8.112031
8.132032
8.152033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Thermo Fisher Scientific22.5
- Sartorius AG10.1
- QIAGEN N.V.11.3
- Brooks Life Sciences6.8
- Cytiva (part of Danaher Corporation)9.0
- Corning Incorporated12.2
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Sample Type10.8%
Storage Type16.1%
End User25.3%
Application31.5%
Service Type16.2%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.9
- Europe24.9
- Asia Pacific18.8
- Latin America13.3
- Middle East and Africa9.1
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | 98 | 91 | 78 | 85 | 94 | 90 | 89 |
| Sartorius AG | 88 | 86 | 86 | 73 | 87 | 71 | 82 |
| QIAGEN N.V. | 71 | 86 | 79 | 87 | 84 | 76 | 81 |
| Brooks Life Sciences | 57 | 71 | 73 | 61 | 74 | 67 | 67 |
| Cytiva (part of Danaher Corporation) | 52 | 70 | 63 | 51 | 64 | 71 | 62 |
| Corning Incorporated | 53 | 66 | 53 | 56 | 68 | 61 | 60 |
| Greiner Bio-One International GmbH | 62 | 54 | 53 | 41 | 59 | 53 | 54 |
| Nexcelom Bioscience LLC | 37 | 48 | 39 | 48 | 35 | 47 | 42 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Thermo Fisher Scientific
- Sartorius AG
- QIAGEN N.V.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | ✓ | ✓ | ✓ | ◐ | ✓ | ✓ |
| Sartorius AG | ◐ | ✓ | ◐ | ◐ | ✓ | ◐ |
| QIAGEN N.V. | ◐ | ✓ | ◐ | ✓ | ✓ | ◐ |
| Brooks Life Sciences | ◐ | ◐ | − | ◐ | ◐ | − |
| Cytiva (part of Danaher Corporation) | − | ◐ | ◐ | − | ◐ | − |
| Corning Incorporated | − | ◐ | − | − | − | ◐ |
| Greiner Bio-One International GmbH | ◐ | ◐ | − | − | ◐ | − |
| Nexcelom Bioscience LLC | − | − | − | ◐ | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Thermo Fisher Scientific89
2Sartorius AG82
3QIAGEN N.V.81
4Brooks Life Sciences67
5Cytiva (part of Danaher Corporation)62
6Corning Incorporated60
7Greiner Bio-One International GmbH54
8Nexcelom Bioscience LLC42
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Thermo Fisher ScientificSartorius AGQIAGEN N.V.
Challenger1
Strong scale, closing on the leaders.
Brooks Life Sciences
Contender2
Focused players with pockets of strength.
Cytiva (part of Danaher Corporation)Corning Incorporated
Niche2
Specialists in a single segment or region.
Greiner Bio-One International GmbHNexcelom Bioscience LLC
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Sample Type in North America, then scale across Bio-Banks Market — a $353M beachhead inside a $6.54B market.
Beachhead (SOM)$353Mobtainable near-term
Serviceable (SAM)$2.39Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
Human Biological Samples
Best fit — highest urgency & budget in Sample Type.
Economic buyer78 fit
Animal Biological Samples
Strong fit — clear ROI and a fast path to value.
End user69 fit
Plant Biological Samples
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Sample Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Storage Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales46%
Partner / channel28%
Digital / self-serve19%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Sample Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Bio-Banks Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified26%
Evaluation12%
Closed-won7%
$21.5KCAC
$92KLTV
4.3:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Bio-Banks Market is a durable-growth opportunity — $1.48B by 2033, compounding at 8.5%.
TAM · 2025$771Mtoday
TAM · 2033$1.48Bforecast
CAGR8.5%2027–2033
Cumulative$9.84Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$1.48BTotal addressable market
SAM$537MServiceable available market
SOM$112MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.5% CAGR
Demand compounds through 2033, outpacing GDP across Sample Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Sample Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$1.48BLarge & growingTAM by 2033 at 8.5% CAGR
$537MServiceable nowreachable with today’s model
$112MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$1.16BBear5.5% CAGR
$1.48BBase8.5% CAGR
$1.90BBull11.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Storage Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Bio-Banks Market — a $1.55B market by 2033. Plan: grow share from 7.1% to 14.2%.
Market size · 2033$1.55Btotal addressable
Market CAGR3.9%2027–2033
Target share14.2%from 7.1% today
Revenue ambition$220Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.1% | 14.2% | Behind |
| Revenue | $100M | $220M | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Ahead |
| Gross margin | 28.3% | 46.0% | Ahead |
| Customer retention | 87.3% | 92.6% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Sample Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Storage Type capability
A defensible second engine — invest in Storage Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Sample Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Storage Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $22M capacity & capability investment
- Greenlight bolt-on M&A in Storage Type
- Authorise North America expansion plan
- Fund R&D program for Sample Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossOn track
- Input-cost & supply riskAhead
- Regulatory / policy changeAhead
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Bio-Banks Market conversation — a $8.46B market you can size, segment and defend in minutes.
Market size · 2033$8.46Btotal opportunity
Growth6.9%CAGR to 2033
Addressable buyers1,749+accounts in scope
Typical ROI6.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Sample Type
Goal Grow share in Sample Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.5×return on cost, year one
< 3 mopayback period
$50K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Thermo Fisher ScientificSartorius AGQIAGEN N.V.Brooks Life SciencesCytiva (part of Danaher Corporation)Corning IncorporatedGreiner Bio-One International GmbHNexcelom Bioscience LLC+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Bio-Banks Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Bio-Banks Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Bioburden Testing Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportBiochip Products and Services Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportBiocompatibility Testing Services Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportBio-imaging Technologies Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportBiologics Safety Testing Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportBioseparation Systems Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportBiosimilar Testing and Development Services Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportBipolar Forceps and Microscissors Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportChromatography Software Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportBleeding Disorders Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportBlood and Organ Bank Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportBlood Collection, Processing, Management Devices, and Consumables Market
Market size, share, segmentation and regional forecast.
$770M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.